Comment on CMS-2026-2212-0001
Association for Accessible Medicines (AAM)SupportTrade association
Summary: The Association for Accessible Medicines (AAM) supports the proposed requirements for PBM compensation and data collection but urges CMS to minimize administrative burdens on manufacturers. They specifically advocate for flexible "bona fide service fee" certifications, the avoidance of mandatory third-party valuations, and more detailed reporting on how administrative fees benefit patients.
Please find attached AAM's comments on the RFI regarding Pharmacy Benefit Manager Compensation and Data Collection